Investment Q&A

Q: dcf.to
Can you please give your opinion on DCF's July 17th news release. It has been very difficult to hold this stock.

Q: Painted pony, surge or tourmaline for most upside in the next 6 months, risk is not a factor . Dave

Q: Western Forest Products, WEF. Whatdo you think of this Co. It has instituted dividend. Looks to be doing very well. I heard that there is a slow market period currently. I had 1000 shares, which I sold as the stock moved up in price. I want to buy, but looking for a bottom. Is this the bottom, or will it fall further. Any idea about the seasonality.I value your opinion a lot. Thanks.

Q: can you comment on XSR results just out. Revenue growth looks good and lower debt costs helpful. Is this a decent entry point for income/growth investors? thanks

Q: Hi Team,

You have mentioned QST favorably in some of the recent questions. Why do you like QST? What are the attributes which make it a good investment? It has been dropping recently on no news. Do you have any insight into that? Thanks

Q: Hello your thoughts on Salix Pharmaceutical SLXP US. Nasdaq
Also PLI. Tsx
Thanks George

Q: Corus was negative net income last quarter. I'm trying to figure out why. Can you give some insights into what happened?

Q: Could you comment please on Questor QST-V. Saw an interview on BNN about this Canadian companies technology to reduce emissions from oilfield flares. Their patent runs through to 2019. Who might be their competition. Thank you.

Q: I am looking for info on WSP GLOBAL concerning the payout ratio and the amount of debt they carry at this time.Thank you for your help.

Q: I hold vermillion energy,vet on Toronto exchange, should we be concerned about its recent declining share price?

Q: Any reason for drop in the price of WSP over the past month?

Q: ITP - Intertape Polymer Group has just boosted its dividend by 50% based on a positive outlook and there has recently been some insider buying. Earnings are due out this August, and the last time that they boosted their dividend, their earnings surprised nicely on the upside. This company seems to be a real cash machine; Good, clean earnings with not a lot of accruals. The company has almost no analyst coverage, yet it is approaching a 1B market cap. This company is yearning for outstanding, conflict free analysis of the type that 5i can provide. Will 5i be covering this company in the near future? What did you think of the dividend boost, proposed share buyback, and stated positive outlook?

Thanks!

Q: Peter, in my diversified portfolio, thinking about adding one riskier stock with a view to growth. Would you pick QST or SPE, without regard for the sector difference. Thanks

Q: re: VXS

Have been sitting on this one for a time. Was reported on BNN to begin watching it move beginning of July with new technologies coming on line that only VXS can satisfy and sure enough it is up 25% since June 25 after technically 2 months of flat performance.

I am seriously considering adding a small position. Is there any comments you can provide that might help me out?

Thanks for all you do for all of us

Gord

Q: Silver Wheaton is often reported as a cyclical stock, and looking at the year chart it certainly appears that way. It's getting up toward its 52 week high again - is it a good idea to sell and wait for a pullback?

Q: Please, your opinion of ATS Automation Tooling Systems -- ATA -- after its current acquisition. Been 5 months since your last comments. And is this a B or better company? Thank you.

Q: Hi Peter and team,

Can you comment on ATD.B's latest results and miss on expectations.

thanks a million!

Q: I am looking at Concordia CXR. I know we have to look forward but this company was .96 a year ago, now around $36. It's not where it was was but where it is going but I can't get my head around the $36 price. I see they only have 14 million shares outstanding so that is a plus. But I am afraid as soon as I buy it they will do a financing to shore up the balance sheet and the stock will fall. Please help me forget where CXR was a year ago and think about the future.

Q: Hello, loving your service. It is very informative. My question is about MCR Macro Enterprises. I bought in January at #6.57. It is now about $4.55. Wondering if I should continue holding or cut my losses. Thanks, Cole

Q: Hello Peter and the 5I research team
I am interested in CXR, it strikes me as begin a potentially great company. It has a great management team and a growing line up of drugs in their stable. It also seems to have great tax rate (blended tax rate in the single digits). Now do you see this company as a great take over candidate from larger US companies? I am thinking this company would be a great take over because of the "Corporate inversion" status that an American company could use with it. My guess is if it was a take over target that the take over would come rather, quickly before the US government can close the inversion tax loop. Does this idea sound possible? What are some of the pro's and con's of this company? Would you add it to a balanced growth portfolio? What do you think about a potential take over for this company?

Thank you